Our initial assessment revealed that ZMYND8 is significantly upregulated in human TNBC-SM lesions, and its high expression correlates with an immunosuppressive tumor microenvironment, characterized by M2 macrophage infiltration, and poor patient survival. This evidence concerns the gene ZMYND8 and neoplasm.